Redhill Biopharma Insider Trades
NASDAQ: RDHLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 3 · $4.42K
- Shares bought / sold
- 0 / 44.18M
- Net activity
- Net selling $4,418
Redhill Biopharma insider activity
Over the last 12 months, Redhill Biopharma insiders reported 3 transactions on SEC Form 4: 0 open-market purchases and 3 sales. Insiders bought $0 and sold $4,418 worth of stock, for net insider selling of $4,418. The largest seller was Raday Gilead, with $4,418 in reported sales.
The most recent filing shows Raday Gilead (Chief Operating Officer) selling 14,310,000 shares at $0.0001 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RDHL's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RDHL insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | Raday GileadChief Operating Officer | Sale | 14,310,000 | $1.43K | Form 4 |
| Jul 10, 2026 | Raday GileadChief Operating Officer | Sale | 14,130,000 | $1.41K | Form 4 |
| Apr 6, 2026 | Raday GileadChief Operating Officer | Sale | 15,740,000 | $1.57K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4